incannex healthcare ltd ixhl ihl announced that its subsidiary company clarion clinics group pty ltd has entered a lease for riverfront premises in abbottsford melbourne the premises will be used to provide psychedelicassisted psychotherapy fit out and commissioning of these premises is due to commence shortly and is expected to be complete in august 2023 facilitating the opening of the first clinic shortly thereafter the clinic is designed as a commercial scale prototype which can be scaled up and replicated to other locations it will have capacity to treat over 600 patients per year in normal working hours and substantially more in extended hour operations incannex has ordered an initial supply of psilocybin and mdma through an arrangement with pharmala biotech to facilitate the commencement of clinical operations incannex ceo and managing director joel latham stated “clarion clinics will be the first dedicated psychedelicassisted psychotherapy business in australia we’re delighted to be at the forefront of an industry that has the potential to change the lives of thousands of people who have been living with conditions for which there have been no adequate treatment options” incannex shares were trading 791 higher at 191 during fridays premarket session photo benzinga edit with photos by geralt and sergeitokmakov on pixabay new clinical mdma and psilocybin batches head to flourishing psychedelics market incannex healthcare prepares to launch psychedelics clinics via new subsidiary